FdaApplication

ANDA 214346

Back to search

Identifiers

Properties

PropertyValue
applicant_nameSENORES PHARMACEUTICALS INC
application_typeANDA
approval_date2022-03-10

Products (1)

ProductActive ingredientStrengthDosage form
NYSTATINNYSTATIN100,000 UNITS/MLSUSPENSION;ORAL

1 product